Abstract

IntroductionThe PIONEER 7 trial demonstrated superior glycemic control and weight loss with once-daily oral semaglutide with flexible dose adjustment versus sitagliptin 100 mg in type 2 diabetes. This 52-week extension...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
...
The Lancet Diabetes & Endocrinology | VOL. 7
, et. al. ...
09 Jun 2019
Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study)
Sho Furusawa ... Shin Aoki
BMJ Open | VOL. 12
Sho Furusawa, et. al.Sho Furusawa ... Shin Aoki
01 May 2022
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
...
The Lancet Diabetes & Endocrinology | VOL. 7
, et. al. ...
09 Jun 2019
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
Stanley Hsia ... Edward Pratt
The Lancet | VOL. 402
Stanley Hsia, et. al.Stanley Hsia ... Edward Pratt
24 Jun 2023
View more papers

More From: BMJ Open Diabetes Research & Care

Paper Title
Journal
Date
Author
Eight-year nationwide study of the bidirectional association between type 2 diabetes and depression in nearly 8 million German outpatients
Woo Ri Chae ... Jakob Holstiege
BMJ Open Diabetes Research & Care | VOL. 12
Woo Ri Chae, et. al.Woo Ri Chae ... Jakob Holstiege
07 May 2024
Unveiling potential therapeutic targets for diabetes-induced frozen shoulder through Mendelian randomization analysis of the human plasma proteome
Kun Chen ... Liangjun Li
BMJ Open Diabetes Research & Care | VOL. 12
Kun Chen, et. al.Kun Chen ... Liangjun Li
07 May 2024
Multidisciplinary proactive e-consults to improve guideline-directed medical therapies for patients with diabetes and chronic kidney disease: an implementation study
Sharon Rikin ... Ladan Golestaneh
BMJ Open Diabetes Research & Care | VOL. 12
Sharon Rikin, et. al.Sharon Rikin ... Ladan Golestaneh
06 May 2024
Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis
Thomas A McCormick ... John L Adams
BMJ Open Diabetes Research & Care | VOL. 12
Thomas A McCormick, et. al.Thomas A McCormick ... John L Adams
06 May 2024
View more papers